Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine Titration Schedule in Schizophrenia
NCT06821945Phase 2Recruiting
- Sponsor
- Boryung
- Start
- May 2025
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olanzapine in schizophrenia, sponsored by Boryung. Started May 2025; status: recruiting.
02
Drugs
olanzapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT06821945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06821945.